SUBSCRIBE
SUBSCRIBE

The Sage Group Finds a Significant Number of New Pharmaceuticals in Clinical Trials for Treatment of Peripheral Arterial Disease

February 13, 2008 | 
1 min read

ATLANTA--(BUSINESS WIRE)--According to a report published by THE SAGE GROUP, research activity has intensified on pharmaceutical treatments for peripheral arterial disease (PAD).